Anavex’s Blarcamesine Shows Reduction in Dementia and Motor Symptoms in Parkinson’s Patients
A year-long extension study of the drug Anavex 2-73 (blarcamesine) has shown promising results for people with Parkinson’s disease dementia, with findings suggesting that it can safely reduce the severity of both dementia and motor symptoms. The study followed 20…
